| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| B7Z653 | cDNA FLJ61657, highly similar to Band 4.1-like protein 1; | NULL | NP_001245258.1;NP_001245259.1;NP_818932.1; | 794 | human |
| B4DY90 | cDNA FLJ56903, highly similar to Tubulin beta-7 chain; | NULL | NP_001280141.1; | 464 | human |
| B4DQ18 | cDNA FLJ55767, highly similar to Lysophosphatidic acid receptor Edg-2; | NULL | NULL | 365 | human |
| E5RIF6 | Hepatitis A virus cellular receptor 1; Fragment; | HAVCR1; | NULL | 223 | human |
| V9GZ00 | Protection of telomeres protein 1; Fragment; | POT1; | NULL | 73 | human |
| B3KN30 | cDNA FLJ13372 fis, clone PLACE1000706, highly similar to Transcription intermediary factor 1-gamma; | NULL | NP_056990.3;NP_148980.2; | 759 | human |
| B7ZKU4 | C12orf51 protein; | C12orf51; | NULL | 653 | human |
| B6D4Y6 | Tyrosine-protein kinase receptor; EC 2.7.10.1; | ALK; | NULL | 1620 | human |
| E7EV75 | Zinc finger MYND domain-containing protein 11; Fragment; | ZMYND11; | NULL | 213 | human |
| E9PJQ7 | Potassium voltage-gated channel subfamily E member 3; Fragment; | KCNE3; | NULL | 12 | human |
| E7ENI9 | Zinc finger MYND domain-containing protein 11; | ZMYND11; | NULL | 571 | human |
| H9KVA9 | Lys-63-specific deubiquitinase BRCC36; | BRCC3; | NULL | 317 | human |
| E7EPI8 | Sodium-dependent lysophosphatidylcholine symporter 1; | MFSD2A; | NP_001274737.1; | 374 | human |
| E7EWT8 | Multidrug resistance protein 1; Fragment; | ABCB1; | NULL | 48 | human |
| E9PFH7 | C-Jun-amino-terminal kinase-interacting protein 3; | MAPK8IP3; | NP_001035529.1; | 1330 | human |
| E9PJ73 | Basic leucine zipper transcriptional factor ATF-like 2; Fragment; | BATF2; | NULL | 155 | human |
| E9PS14 | Extracellular sulfatase Sulf-1; Fragment; | SULF1; | NULL | 85 | human |
| E3T7C0 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| E9PN76 | RING finger protein 214; | RNF214; | NULL | 513 | human |
| E9PND1 | Brain-specific angiogenesis inhibitor 2; Fragment; | BAI2; | NULL | 507 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |